Renal Protection Against Ischemia Perfusion Injury: Hemoglobin Based Oxygen Carrier-201 vs. Blood as an Oxygen Carrier in Ex vivo Subnormothermic Machine Perfusion.
The optimal method of oxygen delivery to donor kidneys during ex vivo machine perfusion has not been established. We have recently reported the beneficial effects of subnormothermic (22°C) blood perfusion in the preservation of porcine DCD kidneys. Since using blood as a clinical perfusate has limitations including matching availability and potential presence of pathogen, we sought to assess hemoglobin-based oxygen carrier, HBOC-201 in oxygen delivery to the kidney for renal protection. Pig kidneys (n=5) were procured following 30 min of warm in situ ischemia by cross-clamping the renal arteries. Organs were flushed with HTK solution and subjected to static cold storage or pulsatile perfusion with an RM3 pump at 22°C for 4h with HBOC-201 and blood. Thereafter, kidneys were re-perfused with normothermic (37°C) oxygenated blood for 4h. Blood and urine were subjected to biochemical analysis. Total urine output, urinary protein, albumin/creatinine ratio, flow rate, resistance were measured. Acute tubular necrosis, apoptosis, urinary kidney damage markers (KIM-1, NGAL) and IL6 were also assessed. HBOC-201 achieved tissues oxygen saturation equivalent to blood. Furthermore, upon reperfusion, HBOC-201 treated kidneys had similar renal blood flow and function compared with blood-treated kidneys. Histologically, HBOC-201 and blood perfused kidneys had vastly reduced ATN scores and degrees of TUNEL staining vs. kidneys treated with cold storage. Urinary damage markers and IL6 levels were similarly reduced by both blood and HBOC-201. HBOC-201 is an excellent alternative to blood as an oxygen carrying molecule in an ex vivo subnormothermic machine perfusion platform in kidneys.